Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDoric Nimrod 3 Regulatory News (DNA3)

Share Price Information for Doric Nimrod 3 (DNA3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.00
Bid: 50.00
Ask: 52.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.00%)
Open: 51.00
High: 51.00
Low: 51.00
Prev. Close: 51.00
DNA3 Live PriceLast checked at -
Doric Nimrod Air Three is an Investment Trust

To obtain income returns and a capital return for its Shareholders by acquiring, leasing and then selling aircraft.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Closing of Finance

15 Jul 2013 15:00

RNS Number : 3468J
Doric Nimrod Air Three Limited
15 July 2013
 



FOR IMMEDIATE RELEASENOT FOR RELEASE IN THE UNITED STATES

DORIC NIMROD AIR THREE LIMITED

Announcement re DNA Alpha Limited

15 July 2013

DNA ALPHA LIMITEDANNOUNCES CLOSING OF $630 MILLION AIRCRAFT FINANCING

St. Peter Port, Guernsey, July 15, 2013- DNA Alpha Limited ("DNA Alpha"), a wholly-owned subsidiary of Doric Nimrod Air Three Limited ("DNA3"), announced that on 12 July 2013 it closed an offering of Class A and Class B enhanced equipment trust certificates (the "Certificates") with an aggregate face amount of $630 million. DNA Alpha intends to use the proceeds from the offerings to finance the acquisition of four new Airbus A380 aircraft to be leased to Emirates scheduled to be delivered from September 2013 to November 2013.

The Class A certificates, with a face amount of $462 million, will bear interest at an annual rate of 5.250% and will have a final expected distribution date of May 30, 2023. The Class B certificates, with a face amount of $168 million, will bear interest at an annual rate of 6.125% and will have a final expected distribution date of November 30, 2019.

Moody's Investors Service rated the Class A Certificates A3 and the Class B Certificates Baa3. Goldman, Sachs & Co. acted as Sole Structuring Agent and Lead Bookrunner, Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC acted as Joint Bookrunners, and Credit Agricole Securities (USA) Inc. acted as Lead Manager.

Application has been made to the Central Bank of Ireland for the Certificates to be admitted to the official list and to be admitted to trading on the regulated market of the Irish Stock Exchange.

DNA3 is a limited liability company organized under the laws of Guernsey that is listed on the London Stock Exchange (LSE: DNA3) and the Channel Islands Stock Exchange (DORICTHR). DNA3 is engaged in the business of acquiring, leasing and selling aircraft.

______________________________________________

This PRESS release is not for PUBLICATION, DISTRIBUTION OR RELEASE IN THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW.

This press release IS NOT an offer to sell or the solicitation of an offer to buy the Certificates, nor shall there be any sales of the Certificates in the united states or any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

The Certificates were not and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES and were offered and sold in the United States only to qualified institutional buyers in accordance with Rule 144A under the Securities Act, and to certain persons outside the United States in reliance on Regulation S under the Securities Act. DNA ALPHA does not intend to register any part of the offering in the United States or to conduct a public offering of securities in the United States. There are no registration rights associated with the Certificates.

 The Certificates may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws.

THIS COMMUNICATION IS AN ADVERTISEMENT AND FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE A PROSPECTUS OR OFFERING MEMORANDUM OR AN OFFER TO ACQUIRE ANY SECURITIES AND IS NOT INTENDED TO PROVIDE THE BASIS FOR ANY CREDIT OR ANY OTHER THIRD PARTY EVALUATION OF THE CERTIFICATES OR THE TRANSACTION (THE "TRANSACTION") AND SHOULD NOT BE CONSIDERED AS A RECOMMENDATION THAT ANY INVESTOR SHOULD SUBSCRIBE FOR OR PURCHASE ANY OF THE CERTIFICATES. ANY INVESTOR WHO ACQUIRES CERTIFICATES MUST RELY SOLELY ON THE FINAL OFFERING CIRCULAR PROVIDED BY DNA ALPHA IN CONNECTION WITH THE TRANSACTION, WHICH CONTAINS DETAILED INFORMATION ABOUT THE COMPANY AND MANAGEMENT AS WELL AS FINANCIAL STATEMENTS, ON THE BASIS OF WHICH ALONE PURCHASES OF OR SUBSCRIPTION FOR THE CERTIFICATES MAY BE MADE.

Following publication, copies of any final offering circular will be made available in an electronic form on the website of the regulated market of the Irish Stock Exchange, at: www.ise.ie.

This communication is directed only at persons who (i) are outside the United Kingdom or (ii) have professional experience in matters relating to investments or (iii) are persons falling within Article 49 (2)(a) to (d) ("high net worth companies, unincorporated associations etc") of The Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (all such persons together being referred to as "relevant persons"). This communication must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this communication relates is available only to relevant persons and will be engaged in only with relevant persons.

 For further information, please contact:

Marc Gordon, Partner, Nimrod Capital LLPTel: +44 20 3355 6850Email: marc.gordon@nimrodcapital.comwww.nimrodcapital.com

Irena Badelska, Partner, Doric Lease CorpTel: +44 207 621 6513Email: irena.badelska@doric.comwww.doric.com

Sally Todd, MHP CommunicationsTel: +44 20 3128 8515Email: Sally.Todd@mhpc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STREADXSFFLDEFF
Date   Source Headline
11th Apr 20245:06 pmRNSQuarterly Factsheet
11th Apr 20245:05 pmRNSDividend Declaration
28th Mar 20249:22 amRNSMSN 133 REDELIVERY CONDITION
15th Mar 20249:24 amRNSMSN 134 REDELIVERY CONDITION
4th Mar 202412:46 pmRNSMSN 136 REDELIVERY CONDITION
11th Jan 20244:21 pmRNSQuarterly Report
11th Jan 20244:19 pmRNSDividend Declaration
4th Jan 20244:07 pmRNSMSN132 REDELIVERY CONDITION
15th Dec 20232:45 pmRNSUnaudited Interim Financial Report
8th Dec 20237:00 amRNSResult of AGM
13th Nov 20233:47 pmRNSNotice of AGM
10th Oct 20234:45 pmRNSQuarterly Report
10th Oct 20234:44 pmRNSDividend Declaration
31st Jul 20234:19 pmRNSResignation of a non-executive director
24th Jul 20235:43 pmRNSAnnual Financial Report
13th Jul 20234:59 pmRNSQuarterly Report
13th Jul 20234:58 pmRNSDividend Declaration
18th Apr 20237:00 amRNSDirectorate Change
13th Apr 20235:04 pmRNSDividend Declaration
13th Apr 20235:04 pmRNSQuarterly Report
4th Apr 20237:00 amRNSDirectorate Change
15th Feb 20237:00 amRNSChange in Board and Board Committee Composition
13th Jan 20234:58 pmRNSQuarterly Report
12th Jan 20235:26 pmRNSDividend Declaration
15th Dec 20225:25 pmRNSHalf-year Report
13th Dec 20229:34 amRNSDirector Declaration
12th Dec 202212:09 pmRNSResult of AGM
15th Nov 20224:45 pmRNSNotice of AGM
13th Oct 20225:21 pmRNSQuarterly Report
13th Oct 20225:19 pmRNSDividend Declaration
23rd Sep 20223:10 pmRNSHolding(s) in Company
22nd Sep 20224:32 pmRNSHolding(s) in Company
8th Aug 20225:12 pmRNSHolding(s) in Company
29th Jul 20226:26 pmRNSAnnual Financial Report
15th Jul 20223:27 pmRNSQuarterly Report
14th Jul 20224:26 pmRNSDividend Declaration
12th Apr 20224:58 pmRNSQuarterly Report
12th Apr 20224:49 pmRNSDividend Declaration
1st Mar 20222:34 pmRNSDirectorate Change
13th Jan 20225:05 pmRNSQuarterly Report
13th Jan 20225:05 pmRNSDividend Declaration
21st Dec 202112:55 pmRNSDirectorate Change
16th Dec 20215:03 pmRNSHalf-year Report
9th Dec 20216:05 pmRNSResult of AGM
27th Oct 20211:14 pmRNSNotice of AGM
14th Oct 20214:00 pmRNSQuarterly Report
14th Oct 20214:00 pmRNSDividend Declaration
1st Oct 20217:00 amRNSHolding(s) in Company
12th Aug 20215:30 pmRNSAnnual Financial Report - Correction
2nd Aug 20216:34 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.